Heterocyclic inhibitors of glut9 for treatment of disease

The present invention relates to heterocyclic compounds and methods which may be useful as inhibitors of GLUT9 for the treatment or prevention of hyperuricemia and gout.

Saved in:
Bibliographic Details
Main Authors BILLEN Denis, ADAMS Nicholas, VELTHUISEN Emile Johann, FENWICK Ashley, WENZLER Marta E, CHOBANIAN Harry, HENKE Brad
Format Patent
LanguageEnglish
Hebrew
Published 01.08.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to heterocyclic compounds and methods which may be useful as inhibitors of GLUT9 for the treatment or prevention of hyperuricemia and gout.
Bibliography:Application Number: IL20240313713